Eli Lilly & Co. (LLY)

• Annual Data
• Quarterly Data

Eli Lilly & Co., Consolidated Statement of Financial Position, Assets

USD $ in thousands

Based on: 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-19), 10-K (filing date: 2014-02-19).

---

Assets, Selected Items

Item	Description	The company
Current assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Eli Lilly & Co.’s current assets increased from 2015 to 2016 and from 2016 to 2017.
Property and equipment, net	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.	Eli Lilly & Co.’s property and equipment, net increased from 2015 to 2016 and from 2016 to 2017.
Noncurrent assets	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.	Eli Lilly & Co.’s noncurrent assets increased from 2015 to 2016 and from 2016 to 2017.
Total assets	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.	Eli Lilly & Co.’s total assets increased from 2015 to 2016 and from 2016 to 2017.

---

Current Assets, Selected Items

Item	Description	The company
Cash and cash equivalents	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.	Eli Lilly & Co.’s cash and cash equivalents increased from 2015 to 2016 and from 2016 to 2017.
Short-term investments	Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.	Eli Lilly & Co.’s short-term investments increased from 2015 to 2016 and from 2016 to 2017.
Accounts receivable, net of allowances	Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.	Eli Lilly & Co.’s accounts receivable, net of allowances increased from 2015 to 2016 and from 2016 to 2017.
Inventories	Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.	Eli Lilly & Co.’s inventories increased from 2015 to 2016 and from 2016 to 2017.